Compare THAR & RDNW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | THAR | RDNW |
|---|---|---|
| Founded | 2017 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 193.3M | 202.9M |
| IPO Year | 2022 | N/A |
| Metric | THAR | RDNW |
|---|---|---|
| Price | $4.64 | $5.53 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $4.00 |
| AVG Volume (30 Days) | ★ 1.2M | 27.9K |
| Earning Date | 11-12-2025 | 03-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $1,095,200,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $7.35 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.95 | $1.46 |
| 52 Week High | $9.08 | $6.58 |
| Indicator | THAR | RDNW |
|---|---|---|
| Relative Strength Index (RSI) | 64.60 | 50.18 |
| Support Level | $2.71 | $4.68 |
| Resistance Level | $5.83 | $5.81 |
| Average True Range (ATR) | 0.50 | 0.41 |
| MACD | 0.20 | -0.04 |
| Stochastic Oscillator | 60.74 | 61.07 |
Tharimmune Inc is a biotechnology company developing a portfolio of therapeutic candidates for rare immune, inflammatory, and oncologic diseases. The Company is progressing towards acquiring a clinical-stage asset known to suppress chronic, debilitating pruritis or uncontrollable itching in primary biliary cholangitis (PBC), a rare orphan liver disease with no known cure. The Company's early-stage immuno-oncology pipeline includes novel multi-specific antibodies targeting epitopes with novel mechanisms of action against validated targets in multiple solid tumors.
RideNow Group Inc is a USA-based online retailer that allows consumers and dealers both to Buy-Sell-Trade-Finance pre-owned motorcycles in an efficient, fast, transparent, and engaging experience.